Investing Port

P/E	593.28
P/S	51.11
P/BV	22.21
EV/EBITDA	374.9
EBITDA	0.01
Цена ао	116.4

Institutions	Объем	Доля, %
Public Mutual Berhad	25000	0.05
Wells Fargo Funds Management LLC	702109	1.44
Delaware Management Company	606284	1.24
Macquarie Investment Management Advisers	72567	0.15
AllianceBernstein LP.	82769	0.17
Brown Advisory LLC	387547	0.8
Wells Fargo Asset Management	529	0
AllianceBernstein Corporation	39882	0.08
Lisanti Capital Growth, LLC	15550	0.03
Wells Capital Management Inc.	117960	0.24
AH Lisanti Capital Growth LLC	93346	0.19
Principal Global Investors, LLC	270695	0.56
Driehaus Capital Management (USVI) LLC	18423	0.04
Perceptive Advisors LLC	848500	1.74
Nationwide Fund Advisors	146491	0.3
SunAmerica Asset Management, LLC	95638	0.2
Heptagon Capital Limited	43342	0.09
Equitable	168917	0.35
Baron Capital Management Inc	89823	0.18
Wells Fargo Funds Management	7790	0.02
Soleus Capital Management, L.P.	65817	0.14
SSGA Funds Management Inc	143636	0.29
Affinity Investment Advisors, LLC	440	0
SEB Investment Management AB	64790	0.13
Santander Private Banking Gestión SGIIC	0	0
Brown Advisory	448	0
Pier Capital, LLC	55932	0.11

ETF	Доля, %	Доходность за год, %
SPDR S&P Health Care Equipment ETF	2	41.90

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.